Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cell Culture Media Market Outlook: Strong 13.2% CAGR to Drive $12.8 Billion Revenue by 2033 - Grand View Research, Inc.

      This image opens in the lightbox

      News provided by

      Grand View Research, Inc.

      19 Nov, 2025, 15:10 GMT

      Share this article

      Share this article


      SAN FRANCISCO, Nov. 19, 2025 /PRNewswire/ -- The global cell culture media market size is expected to reach USD 12.80 billion by 2033, registering a CAGR of 13.20% from 2025 to 2033, according to a new report by Grand View Research, Inc. Cell culture media, typically a liquid or gel, contain the essential compounds necessary to regulate and support the growth of cells and microorganisms vital for manufacturing biopharmaceuticals. A significant factor driving this market is the increasing reliance on cell culture-based viral vaccines, which are now a critical component of global immunization strategies. These methods offer a safer, more efficient, and scalable alternative to traditional egg-based approaches, ensuring high-quality vaccine production that meets rising global demand and stringent safety standards.

      The move toward cell-derived vaccines is accelerating due to critical advantages over older methods. For instance, the CDC noted that from 2020 to 2021, flu vaccine viruses supplied to manufacturers were cell-derived to mitigate the risk of antigenic changes, or mismatches between vaccine strains and circulating viruses, that can occur during egg-based cultivation and reduce effectiveness. Furthermore, the FDA's approval of cell-based candidate vaccine viruses (CVVs) has streamlined the development of more consistent and potentially effective flu vaccines. Beyond influenza, the utility of this technology is broad, extending to the production of vaccines for diseases such as smallpox, rotavirus, rubella, hepatitis, chickenpox, and polio.

      Request a free sample copy of this report: Cell Culture Media Market

      Innovation in cell culture media also significantly supports the burgeoning field of advanced therapeutics. A notable development occurred in December 2024 when Mesoblast received FDA approval for Ryoncil (remestemcel-L), marking it as the first and only mesenchymal stromal cell (MSC) therapy approved in the U.S. for treating steroid-refractory acute graft-versus-host disease (SR-aGvHD) in pediatric patients. This breakthrough therapy is also being developed for other inflammatory conditions, such as biologic-resistant inflammatory bowel disease. The ongoing advancements in biological models, continuous refinement of cell culture media, and the trend toward reducing reliance on animal-derived components are expected to sustain and fuel further innovation in the development of both cell-based vaccines and complex cell therapies.

      Cell Culture Media Market Report Highlights:

      • Based on product, the serum-free media segment dominated the market in 2024 with a 33.16% revenue share, serving as a vital tool that allows researchers to grow specific cell types, enhance consistency and productivity, and significantly reduce the risk of infection.
      • The biopharmaceutical production segment led the market in 2024 with a 47.79% revenue share, primarily driven by the industry's need for more reproducible and defined media to support expanding production and minimize contamination risks in downstream processes.
      • Based on end use, the hospital and diagnostic laboratory segment is projected for significant growth, driven by the increasing use of cell culture media in diagnostic testing and the rising global prevalence of chronic diseases like cancer and autoimmune disorders.
      • North America dominated the market in 2024 with a 38.57% share, primarily attributed to the significant growth of its pharmaceutical and biotechnology industries. This leading position is further reinforced by increasing approvals for cell culture-based vaccines, a rising incidence of diseases like cancer, and substantial investments in cell-based research and development.

      Read full market research report on Cell Culture Media Market with TOC - Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Serum-free Media, Classical Media), By Type (Liquid Media, Semi-solid & Solid Media), By Application (Biopharmaceutical Production), By End-use, By Region, And Segment Forecasts, 2025 - 2033

      Cell Culture Media Market Segmentation

      Grand View Research has segmented the global cell culture media market based on product, application, type, end use, and region:

      Cell Culture Media Market - Product Outlook (Revenue, USD Million, 2021 - 2033)

      • Serum-free Media
        • CHO Media
        • BHK Medium
        • Vero Medium
        • HEK 293 Media
        • Other Serum-free media
      • Classical Media
      • Stem Cell Culture Media
        • Mesenchymal Stem Cells (MSCs)
        • Hematopoietic Stem Cells (HSCs)
        • Induced Pluripotent Stem Cells (iPSCs)
        • Other Stem Cells
      • Immunology Media
        • T Cells
        • B Cells
        • Natural Killer (NK) Cells
        • Other Immune Cells
      • Specialty Media
      • Chemically Defined Media
      • Other Cell Culture Media

      Cell Culture Media Market - Application Outlook (Revenue, USD Million, 2021 - 2033)

      • Biopharmaceutical Production
        • Monoclonal Antibodies
        • Vaccines Production
        • Other Therapeutic Proteins
      • Diagnostics
      • Drug Screening and Development
      • Tissue Engineering and Regenerative Medicine
        • Cell and Gene Therapy
        • Other Tissue Engineering and Regenerative Medicine Applications
      • Other Applications

      Cell Culture Media Market - Type Outlook (Revenue, USD Million, 2021 - 2033)

      • Liquid Media
      • Semi-solid and Solid Media

      Cell Culture Media Market - End Use Outlook (Revenue, USD Million, 2021 - 2033)

      • Pharmaceutical and Biotechnology Companies
      • Hospitals and Diagnostic Laboratories
      • Research and Academic Institutes
      • Other End uses

      Cell Culture Media Market - Regional Outlook (Revenue, USD Million, 2021 - 2033)

      • North America
        • U.S.
        • Canada
        • Mexico
      • Europe
        • UK
        • Germany
        • France
        • Italy
        • Spain
        • Denmark
        • Sweden
        • Norway
      • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
        • Thailand
      • Latin America
        • Brazil
        • Argentina
      • Middle East and Africa
        • South Africa
        • Saudi Arabia
        • UAE
        • Kuwait

      List of Key Players in the Cell Culture Media Market

      • Sartorius AG
      • Danaher
      • Merck KGaA
      • Thermo Fisher Scientific, Inc.
      • FUJIFILM Corporation
      • Lonza
      • BD
      • STEMCELL Technologies
      • Cell Biologics, Inc.
      • PromoCell GmbH

      Check out more related studies published by Grand View Research:

      • Cell Culture Media & Cell Lines Market - The global cell culture media & cell lines market is projected to reach USD 11.25 billion by 2033, growing at a CAGR of 9.63% during the forecast period, according to a new report by Grand View Research, Inc. The market of cell culture media & cell lines is experiencing robust growth, driven by the expanding demand for biologics, cell and gene therapies, regenerative medicine, and advanced vaccine platforms. As biopharmaceutical R&D intensifies globally, there is a growing need for optimized, high-performance media formulations and validated cell lines that ensure consistency, scalability, and regulatory compliance across diverse applications.
      • Cell Culture Media Storage Containers Market - The global cell culture media storage containers market size is anticipated to reach USD 4.26 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.55% from 2025 to 2030. Cell culture media storage containers are equipment or vessels built exclusively for storing cell culture media. The cell culture media containers have been developed to meet the unique needs of cell culture, for example maintaining a sterile environment, reducing evaporation, and protecting against light and temperature variations. Increasing R&D efforts, rising demand for biopharmaceuticals, and technical advances in the industry are propelling market expansion.
      • Cell Culture Market - The global cell culture market size is expected to reach USD 53.17 billion by 2033, registering a CAGR of 11.21% from 2025 to 2033, according to a new report by Grand View Research, Inc. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques.
      • Cell Culture Vitamins Market - The global cell culture vitamins market size is expected to reach USD 343.0 million by 2030 and is expected to grow at 5.6% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has experienced considerable growth as there is an increase in reliance on cell culture technologies across various sectors, particularly in biopharmaceutical research and development.

      Browse Horizon Databook on Cell Culture Media Market – Global Cell Culture Media Market Size & Outlook

      About Grand View Research

      Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

      Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research. Gain insights from 30K+ Global & Regional Reports, 120K+ Country Reports, 1.2M+ Market Statistics, 200K+ Company Profiles, and 5 business solutions encompassing ESG and Sustainability Consulting, Procurement Intelligence, Pricing Index and Analysis, and Consumer Analytics.

      Contact:

      Sherry James
      Corporate Sales Specialist, USA
      Grand View Research, Inc.
      Phone: 1-415-349-0058
      Toll Free: 1-888-202-9519
      Email: sales@grandviewresearch.com
      Web: https://www.grandviewresearch.com
      Blog: https://globalindustryherald.com/
      Follow Us: LinkedIn | Twitter

      Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg 

      Modal title

      Also from this source

      AI in Diagnostics Market to Reach USD 9.7 Billion by 2033, Driven by Rising Demand for Faster and More Accurate Disease Detection

      AI in Diagnostics Market to Reach USD 9.7 Billion by 2033, Driven by Rising Demand for Faster and More Accurate Disease Detection

      The global artificial intelligence in diagnostics market size is expected to reach USD 9.68 billion by 2033, registering a compound annual growth...

      Digital Health Market Size to Reach USD 1,830.4 Billion by 2033, Driven by Rising Adoption of Telehealth, mHealth, AI-Based Solutions, and Connected Healthcare Technologies: Grand View Research, Inc.

      Digital Health Market Size to Reach USD 1,830.4 Billion by 2033, Driven by Rising Adoption of Telehealth, mHealth, AI-Based Solutions, and Connected Healthcare Technologies: Grand View Research, Inc.

      The global digital health market is expected to witness significant expansion over the coming years, with the market size estimated at USD 347.4...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      Biotechnology

      Biotechnology

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.